W
WLC

Topic

regenerative medicine

3 articles on regenerative medicine in longevity medicine. View all news →

FDA Consumer Alert: Regenerative Medicine Products Including Stem Cells and Exosomes Peer-reviewed

Exosome Therapy at Longevity Clinics: Evidence, Regulation, Costs, and Red Flags (2026)

A conservative 2026 guide to exosome therapy longevity clinic offers: evidence, FDA/EU regulation, costs, red flags, and safer alternatives.

Ars Technica: RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Peer-reviewed

Peptide Therapy at Longevity Clinics: What's Legal, What Works & What's Next (2026)

Peptide therapy is the fastest-growing treatment category at longevity clinics. But RFK Jr.'s push to reclassify 12 banned peptides has created confusion. Here's which peptides clinics actually use, what the evidence says, what they cost, and how to choose a clinic.

Frontiers in Aging Peer-reviewed

Best Longevity Clinics for Stem Cell Therapy in 2026

Stem cell therapy for aging jumped from $29.9B (2025) to $31.8B (2026), with allogeneic MSCs dominating. But which clinics offer the best programs? This guide compares top destinations by cell type, protocol, safety, and cost.